Meisner Lara Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
12
Insider Sells Sum
$3.52M

Insider Activity of Meisner Lara

Biography of Meisner Lara

No biography is available at this moment.

2025-09-29SaleBicara Therapeutics Inc. Common Stock
BCAX
Chief Legal Officer
33,807
0.0659%
$14.75$498,653+39.87%
2025-09-15SaleBicara Therapeutics Inc. Common Stock
BCAX
Chief Legal Officer
15,829
0.0293%
$11.49$181,875+66.96%
2025-06-16SaleBicara Therapeutics Inc. Common Stock
BCAX
Chief Legal Officer
15,829
0.0303%
$10.43$165,096+68%
2025-03-14SaleBicara Therapeutics Inc. Common Stock
BCAX
Chief Legal Officer
79,146
0.1511%
$12.90$1.02M+14.05%
2023-06-16SaleViridian Therapeutics, Inc.
VRDN
Chief Legal Officer
27
<0.0001%
$28.35$765-34.59%
2023-06-15SaleViridian Therapeutics, Inc.
VRDN
Chief Legal Officer
2,269
0.0054%
$28.02$63,577-36.35%
2023-06-06SaleViridian Therapeutics, Inc.
VRDN
Chief Legal Officer
5,126
0.0121%
$25.02$128,253-28.07%
2023-06-05SaleViridian Therapeutics, Inc.
VRDN
Chief Legal Officer
499
0.0012%
$25.03$12,490-27.62%
2023-06-02SaleViridian Therapeutics, Inc.
VRDN
Chief Legal Officer
1,875
0.0044%
$24.21$45,394-25.76%
2023-03-09SaleViridian Therapeutics, Inc.
VRDN
General Counsel and Secretary
29,971
0.0733%
$29.07$871,257-33.06%
2023-01-23SaleViridian Therapeutics, Inc.
VRDN
General Counsel and Secretary
6,843
0.0169%
$35.66$244,021-37.4%
2022-12-21SaleViridian Therapeutics, Inc.
VRDN
General Counsel and Secretary
16,326
0.0503%
$29.19$476,556-19.67%
2022-12-16SaleViridian Therapeutics, Inc.
VRDN
General Counsel and Secretary
1,297
0.0041%
$28.44$36,887-14.56%
2022-12-14SaleViridian Therapeutics, Inc.
VRDN
General Counsel and Secretary
15,656
0.0491%
$28.12$440,247-14.61%
2022-11-15SaleViridian Therapeutics, Inc.
VRDN
General Counsel and Secretary
8,125
0.0244%
$22.05$179,156+8.41%
Total: 15
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.